Andrea Belisari

612 total citations
23 papers, 462 citations indexed

About

Andrea Belisari is a scholar working on Economics and Econometrics, Dermatology and Surgery. According to data from OpenAlex, Andrea Belisari has authored 23 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 5 papers in Dermatology and 2 papers in Surgery. Recurrent topics in Andrea Belisari's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Contact Dermatitis and Allergies (5 papers) and Dermatology and Skin Diseases (3 papers). Andrea Belisari is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Contact Dermatitis and Allergies (5 papers) and Dermatology and Skin Diseases (3 papers). Andrea Belisari collaborates with scholars based in Italy, United States and Switzerland. Andrea Belisari's co-authors include LG Mantovani, Paolo Angelo Cortesi, Roberto Raschetti, M. Morgutti, Francesca Menniti‐Ippolito, L Scalone, Lucia Sara D’Angiolella, Giancarlo Cesana, Roberta Ciampichini and Marta Mosca and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Dermatology and Pharmacological Research.

In The Last Decade

Andrea Belisari

19 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Belisari Italy 7 115 112 95 73 69 23 462
Kim Saverno United States 11 117 1.0× 108 1.0× 26 0.3× 48 0.7× 25 0.4× 29 500
Greg Carney Canada 12 53 0.5× 44 0.4× 133 1.4× 36 0.5× 12 0.2× 37 620
Mo Dimbil United States 6 46 0.4× 14 0.1× 70 0.7× 36 0.5× 144 2.1× 7 455
Rolin L. Wade United States 15 133 1.2× 45 0.4× 22 0.2× 53 0.7× 5 0.1× 80 637
Ulf Maywald Germany 14 76 0.7× 42 0.4× 31 0.3× 58 0.8× 6 0.1× 83 890
L Stafford Australia 11 21 0.2× 73 0.7× 64 0.7× 9 0.1× 13 0.2× 24 374
Rosa Romero‐Jiménez Spain 12 47 0.4× 71 0.6× 10 0.1× 87 1.2× 10 0.1× 32 308
Susan Andrade United States 9 34 0.3× 74 0.7× 8 0.1× 95 1.3× 33 0.5× 12 519
Mary E. Ritchey United States 13 97 0.8× 78 0.7× 6 0.1× 41 0.6× 20 0.3× 32 564
Peter J Gilbar Australia 14 44 0.4× 47 0.4× 5 0.1× 115 1.6× 7 0.1× 61 579

Countries citing papers authored by Andrea Belisari

Since Specialization
Citations

This map shows the geographic impact of Andrea Belisari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Belisari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Belisari more than expected).

Fields of papers citing papers by Andrea Belisari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Belisari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Belisari. The network helps show where Andrea Belisari may publish in the future.

Co-authorship network of co-authors of Andrea Belisari

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Belisari. A scholar is included among the top collaborators of Andrea Belisari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Belisari. Andrea Belisari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belisari, Andrea, et al.. (2018). PND41 - HEALTHCARE COSTS OF PATIENTS WITH SPINAL MUSCULAR ATROPHY. Value in Health. 21. S336–S336. 3 indexed citations
2.
Scalone, L, Paolo Angelo Cortesi, Andrea Belisari, Fabio Ayala, & Domenico Bonamonte. (2014). Clinical epidemiology of hand eczema in patients accessing dermatological reference centers: results from a Mediterranean Country. 1 indexed citations
3.
Scalone, L, Paolo Angelo Cortesi, LG Mantovani, et al.. (2014). Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy. British Journal of Dermatology. 172(1). 187–195. 15 indexed citations
4.
Migliore, Alberto, U. Massafra, Emanuele Bizzi, et al.. (2013). Delay of Total Hip Replacement (THR) Using HA Viscosupplementation: Is Cost Effective?. Value in Health. 16(7). A562–A562. 1 indexed citations
5.
Scalone, L, Paolo Angelo Cortesi, Roberta Ciampichini, et al.. (2013). Italian Population-Based Values of EQ-5D Health States. Value in Health. 16(5). 814–822. 111 indexed citations
6.
Cortesi, Paolo Angelo, L Scalone, Andrea Belisari, et al.. (2013). Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. Contact Dermatitis. 70(3). 158–168. 33 indexed citations
7.
Barone, Carlo, Andrea Belisari, Fortunato Ciardiello, et al.. (2012). Cetuximab in first line treatment of metastatic colorectal cancer. SHILAP Revista de lepidopterología. 13(1S). 1–80. 5 indexed citations
8.
Barone, C., Andrea Belisari, Fortunato Ciardiello, et al.. (2012). Cetuximab nel trattamento di prima linea del carcinoma metastatico del colon-retto. 3. 1 indexed citations
9.
Cortesi, Paolo Angelo, L Scalone, O. De Pità, et al.. (2011). PRS17 Prevalence and Cost of Severe Chronic Hand Eczema Refractory to Topical Potent Corticosteroids. Value in Health. 14(7). A490–A490. 2 indexed citations
10.
Cortesi, Paolo Angelo, L Scalone, O. De Pità, et al.. (2011). PSS31 Association Between Eq-5D and Dermatology Life Quality Index (Dlqi) in Patients With Chronic Hand Eczema. Value in Health. 14(7). A507–A507. 1 indexed citations
11.
Belisari, Andrea, et al.. (2010). Economic evaluation of the use of saxagliptin in the treatment of type 2 diabetes in Italy. SHILAP Revista de lepidopterología. 11(2). 103–115. 1 indexed citations
12.
Belisari, Andrea, et al.. (2002). PCV18 OVERWEIGHT AND OBESITY: THE COST TO SOCIETY AND THE ASSOCIATION WITH BODY MASS INDEX. Value in Health. 5(3). 168–168. 1 indexed citations
13.
Mantovani, LG, et al.. (2001). The cost of hospital‐related care of patients with psoriasis in Italy based on the AISP study. Journal of the European Academy of Dermatology and Venereology. 15(4). 320–324. 23 indexed citations
14.
Mantovani, LG, et al.. (2001). The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. Journal of the European Academy of Dermatology and Venereology. 15(4). 320–324.
15.
Belisari, Andrea & LG Mantovani. (2001). Cost-Benefit Analysis of Amtolmetin-Guacil. Clinical Drug Investigation. 21(1). 47–58. 1 indexed citations
16.
Mantovani, LG, Andrea Belisari, & G Dobrilla. (1999). Valutazione economica del lansoprazolo nel trattamento dei pazienti affetti da reflusso esofageo. 1(1). 43–51. 1 indexed citations
17.
Raschetti, Roberto, et al.. (1999). Suspected adverse drug events requiring emergency department visits or hospital admissions. European Journal of Clinical Pharmacology. 54(12). 959–963. 144 indexed citations
18.
Mantovani, LG, Andrea Belisari, & Thomas D. Szucs. (1998). CAPTOPRIL IN THE MANAGEMENT OF PATIENTS AFTER ACUTE MYOCARDIAL INFARCTIONS. A COST EFFECTIVENESS ANALYSIS IN ITALY. Pharmacological Research. 37(5). 345–351. 4 indexed citations
19.
Szucs, Thomas D., Andrea Belisari, & LG Mantovani. (1998). Can Europe afford not to implement evidence-based medicine in heart failure?. PubMed. 19 Suppl L. L22–7.
20.
Szucs, Thomas D., Andrea Belisari, & LG Mantovani. (1997). Is Preventive Medical Care Worth the Cost?. Biologicals. 25(2). 247–252. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim Saverno Breakdown of academic impact, for papers by Greg Carney Breakdown of academic impact, for papers by Mo Dimbil Breakdown of academic impact, for papers by Rolin L. Wade Breakdown of academic impact, for papers by Ulf Maywald Breakdown of academic impact, for papers by L Stafford Breakdown of academic impact, for papers by Rosa Romero‐Jiménez Breakdown of academic impact, for papers by Susan Andrade Breakdown of academic impact, for papers by Mary E. Ritchey Breakdown of academic impact, for papers by Peter J Gilbar
Rankless by CCL
2026